The evolution of mendelian randomization for investigating drug effects
Publication Date
2022-02-03Journal Title
PLOS Medicine
ISSN
1549-1277
Publisher
Public Library of Science
Volume
19
Issue
2
Language
en
Type
Other
This Version
VoR
Metadata
Show full item recordCitation
Gill, D., & Burgess, S. (2022). The evolution of mendelian randomization for investigating drug effects. [Other]. https://doi.org/10.1371/journal.pmed.1003898
Abstract
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.
Keywords
Perspective, Biology and life sciences, Medicine and health sciences
Identifiers
pmedicine-d-21-05010
External DOI: https://doi.org/10.1371/journal.pmed.1003898
This record's DOI: https://doi.org/10.17863/CAM.81024
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk